The best offense is a good beta-defensin

Area of Science:

• Immunology
• Microbiology
• Dermatology

Background:

• Antimicrobial peptides (AMPs) play crucial roles in innate immunity.
• The specific receptors mediating AMPs' immunologic effects, particularly on neutrophils, are not fully understood.
• Understanding these interactions is key to developing new strategies for cutaneous defense and microbiome modulation.

Purpose of the Study:

• To identify novel receptors involved in the immunologic effects of antimicrobial peptides.
• To elucidate the role of specific receptors in neutrophil activation and cutaneous immunity.
• To investigate the impact of AMP-receptor interactions on skin microbiome composition.

Main Methods:

• Utilized genetic screening and molecular biology techniques to identify potential receptors.
• Performed binding assays to confirm interactions between beta-defensins and identified receptors.
• Conducted functional assays using neutrophils to assess granule release and cytokine production (e.g., IL-1β).
• Analyzed changes in skin microbiome composition following receptor activation.

Main Results:

• Identified Mgrpra2, a G-protein coupled receptor expressed on neutrophils, as a key receptor for keratinocyte-derived beta-defensins.
• Demonstrated that binding of beta-defensins to Mgrpra2 triggers the release of neutrophil granules and Interleukin-1 beta (IL-1β).
• Showcased that this signaling pathway modulates the skin microbiome and enhances defense against bacterial infections.

Conclusions:

• Mgrpra2 is a critical receptor mediating the immunologic functions of beta-defensins on neutrophils.
• The Mgrpra2-beta-defensin axis plays a significant role in shaping the skin microbiome and bolstering cutaneous immunity.
• This discovery opens new avenues for therapeutic interventions targeting skin infections and microbiome dysbiosis.